Stay updated on EMPIRE CF: CTX-4430 Clinical Trial

Sign up to get notified when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EMPIRE CF: CTX-4430 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The changes appear to be minor UI/layout updates to the Study Details page with no impact on core trial information such as eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:18:58.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    3%
    Check dated 2025-10-05T10:21:57.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Update to v3.1.0 with removal of several named drug-safety topics from the page, indicating a scope shift and version upgrade.
    Difference
    0.4%
    Check dated 2025-09-28T03:21:48.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, replacing the older tag. The 'Back to Top' link was removed, indicating a minor UI cleanup.
    Difference
    0.2%
    Check dated 2025-09-13T17:40:17.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-06T15:22:04.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific locations related to drug safety and cystic fibrosis, while also removing previous location terms and some medical terminology.
    Difference
    2%
    Check dated 2025-08-30T11:54:29.000Z thumbnail image

Stay in the know with updates to EMPIRE CF: CTX-4430 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.